Copyright
©The Author(s) 2015.
World J Cardiol. Sep 26, 2015; 7(9): 544-554
Published online Sep 26, 2015. doi: 10.4330/wjc.v7.i9.544
Published online Sep 26, 2015. doi: 10.4330/wjc.v7.i9.544
Figure 1 Overview of multiple effectors for the heterogeneity of the heart failure has preserved left ventricular ejection fraction syndrome.
COPD: Chronic obstructive pulmonary disease; HFpEF: Heart failure has preserved left ventricular ejection fraction.
- Citation: Becher PM, Fluschnik N, Blankenberg S, Westermann D. Challenging aspects of treatment strategies in heart failure with preserved ejection fraction: “Why did recent clinical trials fail?”. World J Cardiol 2015; 7(9): 544-554
- URL: https://www.wjgnet.com/1949-8462/full/v7/i9/544.htm
- DOI: https://dx.doi.org/10.4330/wjc.v7.i9.544